InvestorsObserver
×
News Home

Repligen Corporation (RGEN) is down -12.00% in a Week, Should You Accumulate?

Monday, April 11, 2022 03:24 PM | InvestorsObserver Analysts

Mentioned in this article

Repligen Corporation (RGEN) is down -12.00% in a Week, Should You Accumulate?

A rating of 78 puts Repligen Corporation (RGEN) near the top of the Medical Instruments & Supplies industry according to InvestorsObserver. Repligen Corporation's score of 78 means it scores higher than 78% of stocks in the industry. Repligen Corporation also received an overall rating of 53, putting it above 53% of all stocks. Medical Instruments & Supplies is ranked 116 out of the 148 industries.

Overall Score - 53
RGEN has an Overall Score of 53. Find out what this means to you and get the rest of the rankings on RGEN!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 53 means the stock is more attractive than 53 percent of stocks.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Repligen Corporation Stock Today?

Repligen Corporation (RGEN) stock is trading at $164.48 as of 3:24 PM on Monday, Apr 11, a loss of -$5.50, or -3.24% from the previous closing price of $169.98. The stock has traded between $162.64 and $167.49 so far today. Volume today is 434,677 compared to average volume of 414,135. Click Here to get the full Stock Report for Repligen Corporation stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App